AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/100
IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: DEFABRITIIS P AMADORI S PETTI MC MANCINI M MONTEFUSCO E PICARDI A GEISER T CAMPBELL K CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Leukemia, 9(4), 1995, pp. 662-664
CYTOGENETIC ANALYSIS IS NON-INFORMATIVE FOR ASSESSING THE REMISSION RATE IN CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS ON INTERFERON-ALPHA (IFN-ALPHA) THERAPY
Authors: COXFRONCILLO MC CANTONETTI M MASI M LENTINI R GIUDICEANDREA P MAFFEI L TRIBALTO M AMADORI S PAPA G
Citation: Mc. Coxfroncillo et al., CYTOGENETIC ANALYSIS IS NON-INFORMATIVE FOR ASSESSING THE REMISSION RATE IN CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS ON INTERFERON-ALPHA (IFN-ALPHA) THERAPY, Cancer genetics and cytogenetics, 84(1), 1995, pp. 15-18
MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS
Authors: FALINI B VENTURI S MARTELLI M SANTUCCI A PILERI S PESCARMONA E GIOVANNINI M MAZZA P MARTELLI MF PASQUALUCCI L BALLATORI E GUGLIELMI C AMADORI S POGGI S SABATTINI E GHERLINZONI F ZINZANI PL BARONI CD MANDELLI F TURA S
Citation: B. Falini et al., MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS, British Journal of Haematology, 89(4), 1995, pp. 780-789
MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - CYTOCHEMICAL, IMMUNOPHENOTYPIC AND CYTOGENETIC ANALYSIS OF 19 CASES (VOL 88, PG 784, 1994)
Authors: VENDITTI A DELPOETA G STASI R MASI M BRUNO A BUCCISANO F COX C COPPETELLI U ARONICA G SIMONE MD TRIBALTO M AMADORI S PAPA G
Citation: A. Venditti et al., MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - CYTOCHEMICAL, IMMUNOPHENOTYPIC AND CYTOGENETIC ANALYSIS OF 19 CASES (VOL 88, PG 784, 1994), British Journal of Haematology, 89(3), 1995, pp. 692-692
HIGH-LEVELS OF BCL-2 PROTEIN DO NOT AFFECT PROGNOSIS IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: DELPOETA G VENDITTI A STASI R ARONICA G BRUNO A BUCCISANO F COX C MAFFEI L CARAVITA T SUPPO G PICCIONI D SANTINELLI S MASI M TRIBALTO M PAPA G AMADORI S
Citation: G. Delpoeta et al., HIGH-LEVELS OF BCL-2 PROTEIN DO NOT AFFECT PROGNOSIS IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 151-151
BIOLOGICAL AND CLINICAL-EVALUATION OF 24 CASES OF MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO)
Authors: VENDITTI A DELPOETA G STASI R BUCCISANO F ARONICA G BRUNO A COX C MAFFEI L TAMBURINI A FORTE L CORDERO V MASI M TRIBALTO M PAPA G AMADORI S
Citation: A. Venditti et al., BIOLOGICAL AND CLINICAL-EVALUATION OF 24 CASES OF MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO), Blood, 86(10), 1995, pp. 152-152
IS CONVENTIONAL CYTOGENETICS AN EFFECTIVE APPROACH FOR MONITORING DISEASE IN CML PATIENTS ON INTERFERON (IFN) THERAPY
Authors: COXFRONCILLO MC CANTONETTI M MAFFEI L LENTINI R MASI M GIUDICEANDREA P BRUNO A BUCCISANO F CORDERO V FORTE L TAMBURINI A TRIBALTO M PAPA G AMADORI S
Citation: Mc. Coxfroncillo et al., IS CONVENTIONAL CYTOGENETICS AN EFFECTIVE APPROACH FOR MONITORING DISEASE IN CML PATIENTS ON INTERFERON (IFN) THERAPY, Blood, 86(10), 1995, pp. 2098-2098
PROGNOSTIC CLASSIFICATION OF MULTIPLE-MYELOMA PATIENTS BY USING A NEURAL-NETWORK SOFTWARE
Authors: BUGLIOSI R TRIBALTO M BOCCADORO M PEEST D CARATOZZOLO A PETRUCCI MT AMADORI S
Citation: R. Bugliosi et al., PROGNOSTIC CLASSIFICATION OF MULTIPLE-MYELOMA PATIENTS BY USING A NEURAL-NETWORK SOFTWARE, Blood, 86(10), 1995, pp. 3310-3310
FIRST-LINE TREATMENT OF DE-NOVO MULTIPLE-MYELOMA WITH AUTOLOGOUS CIRCULATING PROGENITORS CELLS TRANSPLANTATION - AN ITALIAN MULTICENTRIC STUDY
Authors: TRIBALTO M BUGLIOSI R CARAVITA T CUDILLO L DELPOETA G ANDRIANI A AVVISATI G LAVERDE G MELONI G LEONE G MENICHELLA G MARTELLI M TABILIO A FIORITONI G IACONE P MAJOLINO I MARCENO R AMADORI S MANDELLI F
Citation: M. Tribalto et al., FIRST-LINE TREATMENT OF DE-NOVO MULTIPLE-MYELOMA WITH AUTOLOGOUS CIRCULATING PROGENITORS CELLS TRANSPLANTATION - AN ITALIAN MULTICENTRIC STUDY, Blood, 86(10), 1995, pp. 3862-3862
LONG-TERM OBSERVATION OF 208 ADULTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Authors: STASI R STIPA E MASI M CECCONI M SCIMO MT OLIVA F SCIARRA A PERROTTI AP ADOMO G AMADORI S PAPA G
Citation: R. Stasi et al., LONG-TERM OBSERVATION OF 208 ADULTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA, The American journal of medicine, 98(5), 1995, pp. 436-442
MYELODYSPLASTIC SYNDROMES IN CHILDHOOD - DESCRIPTION OF 7 CASES
Authors: VITALE A TESTI AM MOLETI ML VIGNETTI M ARCESE W FENU S CEDRONE M DEFELICE L AMADORI S MANDELLI F
Citation: A. Vitale et al., MYELODYSPLASTIC SYNDROMES IN CHILDHOOD - DESCRIPTION OF 7 CASES, Annals of hematology, 68(5), 1994, pp. 241-245
MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - CYTOCHEMICAL, IMMUNOPHENOTYPIC AND CYTOGENETIC ANALYSIS OF 19 CASES
Authors: VENDITTI A DELPOETA G STASI R MASI M BRUNO A BUCCISANO F COX C COPPETELLI U ARONICA G SIMONE MD PAPA G TRIBALTO M AMADORI S
Citation: A. Venditti et al., MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-MO) - CYTOCHEMICAL, IMMUNOPHENOTYPIC AND CYTOGENETIC ANALYSIS OF 19 CASES, British Journal of Haematology, 88(4), 1994, pp. 784-793
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - RESULTS OF A PROSPECTIVE CLINICOPATHOLOGICAL STUDY OF 69 CASES/
Authors: PILERI S BOCCHIA M BARONI CD MARTELLI M FALINI B SABATTINI E GHERLINZONI F AMADORI S POGGI S MAZZA P BURGIO V ZINZANI PL MELILLI G BENNI M SARAGONI L MARTELLI MF STEIN H MANDELLI F TURA S
Citation: S. Pileri et al., ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+ KI-1+) - RESULTS OF A PROSPECTIVE CLINICOPATHOLOGICAL STUDY OF 69 CASES/, British Journal of Haematology, 86(3), 1994, pp. 513-523
TREATMENT OF PRIMARY REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN AND ADULTS - THE GIMEMA AIEOP-ASTERISK EXPERIENCE/
Authors: GIONA F TESTI AM ANNINO L AMADORI S ARCESE LW CAMERA A DIMONTEZEMOLO LC LADOGANA S LISO V MELONI G MOLETI ML RONDELLI R ZANESCO BL PESSION A MANDELLI F
Citation: F. Giona et al., TREATMENT OF PRIMARY REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN AND ADULTS - THE GIMEMA AIEOP-ASTERISK EXPERIENCE/, British Journal of Haematology, 86(1), 1994, pp. 55-61
ABERRANT EXPRESSION OF CYCLINS AND CYCLIN-DEPENDENT KINASES IN ACUTE-LEUKEMIA PATIENTS
Authors: PETRUCCI MT MASCOLO MG RICCIARDI MR AMADORI S MANDELLI F TAFURI A
Citation: Mt. Petrucci et al., ABERRANT EXPRESSION OF CYCLINS AND CYCLIN-DEPENDENT KINASES IN ACUTE-LEUKEMIA PATIENTS, Blood, 84(10), 1994, pp. 10000040-10000040
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VS DHAP IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) PARTIALLY RESPONDING TO 1ST LINE CHEMOTHERAPY
Authors: GHERLINZONI F MARTELLI M MAZZA P ZINZANI PL PILERI S BOCCHIA M MELONI G VIGNETTI M GUGLIELMI C AMADORI S ANTIMI M BURGIO VL MARTELLI MF FALINI B LIBERATI AM BENDANDI M MIGGIANO MC CALABRESI F DAMMACCO F LUCARELLI G MORETTI L MANDELLI F TURA S
Citation: F. Gherlinzoni et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VS DHAP IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) PARTIALLY RESPONDING TO 1ST LINE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000234-10000234
YNK01, AN ORAL ARA-C DERIVATIVE IN PATIENTS WITH AML, MDS, LOW-GRADE MALIGNANT NHL AND CML
Authors: HEUSSNER P WILLEMZE R GANSER A HANAUSKE A AMADORI S HEIL G SCHLEYER E HIDDEMANN W SELBACH J SCHUSSLER M FREUND M
Citation: P. Heussner et al., YNK01, AN ORAL ARA-C DERIVATIVE IN PATIENTS WITH AML, MDS, LOW-GRADE MALIGNANT NHL AND CML, Blood, 84(10), 1994, pp. 10000302-10000302
IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGONUCLEOTIDES DOES NOT AFFECT HEMATOPOIETIC RECONSTITUTION AFTER AUTOGRAFT IN PATIENTS WITH CML IN ADVANCED PHASE
Authors: DEFABRITIIS P AVVISATI G MANCINI M LISCI A MONTEFUSCO E SALA R CAMPBELL K GEISER T AMADORI S CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGONUCLEOTIDES DOES NOT AFFECT HEMATOPOIETIC RECONSTITUTION AFTER AUTOGRAFT IN PATIENTS WITH CML IN ADVANCED PHASE, Blood, 84(10), 1994, pp. 10000727-10000727
MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA
Authors: SPADEA A PETTI MC FAZI P VEGNA ML ARCESE W AVVISATI G SPIRITI MAA LATAGLIATA R MELONI G TESTI AM AMADORI S MANDELLI F
Citation: A. Spadea et al., MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA, Leukemia, 7(4), 1993, pp. 549-552
PROSPECTIVE COMPARATIVE-STUDY OF BONE-MARROW TRANSPLANTATION AND POSTREMISSION CHEMOTHERAPY FOR CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA
Authors: AMADORI S TESTI AM ARICO M COMELLI A GIULIANO M MADON E MASERA G RONDELLI R ZANESCO L MANDELLI F
Citation: S. Amadori et al., PROSPECTIVE COMPARATIVE-STUDY OF BONE-MARROW TRANSPLANTATION AND POSTREMISSION CHEMOTHERAPY FOR CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 11(6), 1993, pp. 1046-1054
P-VABEC - A PROSPECTIVE-STUDY OF A NEW WEEKLY CHEMOTHERAPY REGIMEN FOR ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: MARTELLI M GUGLIELMI C COLUZZI S AVVISATI G AMADORI S GIOVANNINI M TORROMEO C MANDELLI F
Citation: M. Martelli et al., P-VABEC - A PROSPECTIVE-STUDY OF A NEW WEEKLY CHEMOTHERAPY REGIMEN FOR ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(12), 1993, pp. 2362-2369
P-VABEC - A NEW CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) IN ELDERLY PATIENTS
Authors: MARTELLI M GUGLIELMI C AMADORI S ROMANI C GIOVANNINI M BIZZONI L MANDELLI F
Citation: M. Martelli et al., P-VABEC - A NEW CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) IN ELDERLY PATIENTS, Journal of cellular biochemistry, 1993, pp. 266-266
ELIMINATION OF CLONOGENIC PHILADELPHIA-POSITIVE CELLS USING BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES
Authors: DEFABRITIIS P AMADORI S CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., ELIMINATION OF CLONOGENIC PHILADELPHIA-POSITIVE CELLS USING BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES, Bone marrow transplantation, 12(3), 1993, pp. 261-265
TREATMENT OF REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA IN BLASTIC PHASE (CML-BP) WITH VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN
Authors: AMADORI S FAZI P PETTI MC PICARDI A CARUSO R MANDELLI F
Citation: S. Amadori et al., TREATMENT OF REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA IN BLASTIC PHASE (CML-BP) WITH VP-16, INTERMEDIATE-DOSE ARA-C AND CARBOPLATIN, Blood, 82(10), 1993, pp. 10000131-10000131
EFFECTS OF INTERLEUKIN-7, STEM-CELL FACTOR AND GM-CSF IL-3 FUSION PROTEIN ON SURVIVAL AND PROLIFERATION OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS
Authors: PETRUCCI MT TAFURI A MASCOLO MG DEFELICE L BURBA L ANNINO L MOLETI L AMADORI S MANDELLI F
Citation: Mt. Petrucci et al., EFFECTS OF INTERLEUKIN-7, STEM-CELL FACTOR AND GM-CSF IL-3 FUSION PROTEIN ON SURVIVAL AND PROLIFERATION OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS, Blood, 82(10), 1993, pp. 10000504-10000504
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>